QualityDipStocks / Industrials · Industrial machinery
ChronoScale CHRN
Outside our quality screen, so we don’t track its dips. It’s 56% below its 52-week high.
Outside our quality screen, trading well above our fair value estimate, 17% under its Market Value.
- Fair value est.
- $2.68−79%
- Market Value
- $15.64price −17%
- Off 52-wk high
- −56%
- Risk vs market
- Highbeta 3.26
52-week range 36% of the way from its 52-week low to its high
Price $13.03Fair value est. $2.68Market Value $15.64
3 bullish · 5 bearish See why
Valuation
What we estimate it's worth, and how it ranks on value vs every stock we cover.
Fair value estimate
How the range is computed
Ten-year free-cash-flow DCF. Same 10-year free-cash-flow model as the base: discount rate 9.5% ±1 point and growth 3.0% ±2 points. Bear = 10.5% and 1.0%; bull = 8.5% and 5.0% (both fade to 3%). A model estimate from public filings, not a forecast of where the price will go.
Price is above even the bull case.
What the price implies To be worth today’s price, CHRN’s free cash flow would need to grow about 32% a year for five years; our estimate uses 3%.
Risk vs market
How risk vs market is measured
One year of daily returns (Oct 31 to Nov 2, 252 sessions). Beta = how much CHRN moved for each 1% move in the S&P 500 (SPY); 1.0 moves with the market. Volatility is the yearly standard deviation of daily returns. Past behavior, not a forecast.
Swings much more than the market, and its own price swings are 11.4× the S&P 500’s.
- Beta vs S&P 500
- 3.26
- Volatility
- 145% vs 13% SPY
- Correlation SPY
- 0.29
- Correlation QQQ
- 0.31
How it ranks
Where CHRN stands vs every one of the 2,467 stocks we cover that has the number. Longer bar = better.
Not in the top quarter on any of these 5 measures
- Discount to fair value estimate79% · price above our base caseLowest 2%of 1,507
- Free cash flow yield1.3% · free cash flow vs market capLowest 26%of 1,690
- Dividends + buybacks yield0% · cash paid out or used to retire shares, vs market capLowest 1%of 2,227
- Operating margin−56% · of sales kept as operating profitLowest 3%of 1,549
- Return on invested capital−29% · profit per dollar of capitalLowest 3%of 1,001
From SEC filings and our fair value estimate model. A ranking, not advice.
Valuation details
DCF $2.68 · MV $15.64 · FCF value $3.43
Assumes 3.0% growth for 5 years (revenue grew -15.1% a year FY25–FY26; floored at 3%), fading to 3%; 9.5% discount rate, 3% terminal growth. FCF base $0.17 a share (trailing 12 months to Aug 31, 2026), from the 10-Q filed Oct 14, 2026. Net cash $5M, not added.
Fundamentals
The business itself: sales, profits, cash and debt, from SEC filings.
Bull vs bear
Rule-based from the data on this page, strongest first. Not advice.
Top bullish points 3 of 5
Balance sheetDebt / equity of 0.1×, below the 0.6× median for the 224 Industrials companies we cover.
Balance sheetNet cash of $5M: cash and short-term investments exceed debt (Aug 31, 2026).
ValuationTrades 16.7% below its Market Value of $15.64, the average price paid since the Oct 15 filing.
Top bearish points 5 of 5
ValuationOur DCF fair value estimate is $2.68, 79% below the price.
ProfitabilityLost $82M over the last 12 months (net income, SEC filings).
ProfitabilityLoses money at the operating line: −56% operating margin over the last 12 months.
QualityDoesn’t pass our quality screen: ROE under 12% and ROIC under 10%; net debt 9.5× EBITDA (limit 3×).
RiskSwings hard: beta 3.26 vs the S&P 500 and 145% yearly volatility (SPY 13%).
All fundamentals
FCF yield 1.3% · ROE -68%
Valuation
- P/E
- n/aloss over the last 12 months
- Price / FCF
- 76.9×
- FCF yield
- 1.3%
- EV / EBITDA
- n/an/m: EBITDA near zero
- Price / sales
- 19.66×
- Price / book
- 12.58×
- Market cap
- $1.9Bprice × diluted shares
- Enterprise value
- $1.9B
Growth
- Revenue, 12 months
- $96M
- Sales growth, 12 months
- n/ano year-ago 12-month revenue
- Sales growth, 3 yrs
- n/anot reported in its SEC filings
- Diluted EPS, 12 months
- −$0.57
- EPS growth, last FY
- n/afewer than two years of diluted EPS
- Net income, 12 months
- −$82M
- Net income growth
- n/anot reported in its SEC filings
Profitability
- Gross margin
- −14.6%
- Operating margin
- −56.4%
- Net margin
- −84.9%
- FCF margin
- 25.6%
- Return on equity
- −68%
- Return on invested capital
- −29%
Balance sheet
- Cash & short-term inv.
- $15M
- Total debt
- $11M
- Net cash
- $5M
- Debt / equity
- 0.07×
- Interest coverage
- n/ainterest expense not tagged in SEC data
Cash flow & returns
- Free cash flow, 12 months
- $25M
- FCF growth, 12 months
- n/anot reported in its SEC filings
- Dividend yield
- 0%
- Payout ratio
- n/anot reported in its SEC filings
- Buybacks, 12 months
- n/anot reported in its SEC filings
- Share count, 1 year
- +5.2%diluted shares vs a year ago
- Stock-based comp
- $11M
Trailing 12 months to Aug 31, 2026; balance sheet at Aug 31, 2026. From ChronoScale’s SEC filings. Sparklines show up to six fiscal years. n/a means we don’t hold that number, with the reason. How each is computed.
The business
FCF $0.0B · Sales +148%
- Free cash flow, 12 months$0.0B
- Free-cash-flow yield1.3%
- Gross margin−15%
- Operating margin−60%
- Return on invested capital−19%
- Sales growth (latest quarter vs year-ago quarter)+148%
- Net debt / EBITDA9.5×
Chart & levels
Where the price is vs its key levels and trends.
Key levels
Every level vs today’s $13.03
- Fair value est.base case$2.68−79.4%
- 52-wk lowlowest close, 1 year$3.87−70.3%
- PriceMon Nov 2 close$13.03you are here
- Market Valueavg paid since Oct 15$15.64+20.0%
- 52-wk highhighest close, 1 year$29.63+127.4%
Momentum & 52-week range
RSI 35 · 5 days −10.9%
Signals
Reversal signal setups, the public ledger and the next earnings date.
Setup & signals
No setup armed
No setup armed, so there’s no trigger or stop to track yet. Reversal signal rules only run on companies that pass our quality screen.
CHRN is outside our quality screen
One text when a published rule fires on one of the 332 quality companies we track: the ticker, the price, the stop and a link to the numbers. Nothing else.
Voices & buzz
Who is talking about it, and how it compares with peers.
Who’s talking about it
Notable investors, executives, analysts and public figures on ChronoScale in the last 48 hours. Headlines as published, each linked. Their words, not ours.
No notable mentions in the last 48 hours. Checked Nov 3, 5:14 PM ET.
Compare with peers
Closest in size in Industrial machinery
Information only, not investment advice. Fair value estimates and talking points are rule-based model output from public data and can be wrong; stop levels are reference points, not orders. How every number is computed.